Trasylol Class Action Lawsuit Information. More about the drug injury lawsuit

Trasylol Class Action Lawsuit Information. More about the drug injury lawsuit - By: Jhoana Cooper, Posted on: 2008-08-21

Trasylol heart surgery stroke lawsuit was created in order to compensate patients due to the side effects of this controversial heart surgery drug. Good medicine should be all about providing the patient with the best and safest drugs on the planet. Bayer’s popular Trasylol medication was recalled late in 2007 due to side effects linked with its use in bypass surgery patients. There are plenty of dangers and complications that are related to this drug and the people who are already suffering from its side effects should seek legal representation to protect their rights.

Bayer's Trasylol problems are growing as they face thousand of potential lawsuits following increasing reports of their heart surgery drug's side effects. Trasylol has recently been linked to a higher risk of kidney failure, heart attack, and death in the five years following a patient undergoing bypass heart surgery. In 1993 Trasylol (Aprotinin) was approved by the Federal Drug Administration. Aprotinin is manufactured by Bayer under the brand name Trasylol.

Most heart surgery patients and families of patients who died following bypass surgery don't know if they were given Trasylol during their open heart surgery. Many patients suffering from Trasylol side effects such as kidney failure or heart failure don't know if they were given Trasylol during their surgery because the heart medication was given during the bypass procedure.

Trasylol affects the way in which blood clots. It is given to open heart surgery patients to help prevent excessive bleeding. Trasylol is mainly used during repeat coronary artery bypass (CABG) surgery to reduce the amount of bleeding both during and after surgery. Until being pulled from the market late in 2007, the drug had been in use for 13 years and a million patients had received it. One of the most serious complications for bypass surgery patients is excessive bleeding. Clotting medications such as Trasylol reduce the amount of blood transfusion needed during surgery. In 2006 The New England Journal of Medicine (NEJM) published a study that reported Trasylol side effects with an increased risk of developing heart failure, kidney failure, myocardial infarction, and stroke in bypass heart surgery patients.

On September 21, 2006 the FDA's Cardiovascular and Renal Drug Advisory Committee met to discuss current data regarding Trasylol problems. On September 29, 2006, the FDA issued a public health advisory stating that it had new information that Bayer neglected to disclose an earlier study it had conducted involving 67,000 heart surgery patients. Preliminary review of this study suggested that Trasylol side effects included higher risks for stroke, congestive heart failure, kidney failure, and death. Bayer failed to disclose this study during the Advisory Committee on September 21, 2006.

Dr. Dennis Mangano, the lead author of the NEJM Trasylol side effects study, has noted that Trasylol problems occurred more frequently than those linked with the drug Vioxx. Dr. Mangano relates, "In fact our findings raise even more troubling concerns, for:
(1) aprotinin has been on the market for three times as long as Vioxx, yet few comprehensive safety studies have been conducted since approval;
(2) the life-threatening complications with aprotinin found here occurred far more frequently than those with Vioxx; and
(3) far less expensive generic alternatives to aprotinin which are equally effective in limiting bleeding have been available, but have been underused."

The observational study concluded, "Our findings raise serious concerns regarding the safety of an approved drug intended to limit blood loss in at-risk patients undergoing surgery." Mangano related his opinion regarding the ongoing use of Trasylol, stating "In good conscience, I could not administer (Trasylol) to this group of patients, especially given the availability of safer alternatives." Trasylol problems continue to be studied and the number of patients affected by the drug continues to rise as the public becomes more aware of the drugs devastating side effects.

Article Source:- Directory Submission & Sexy Deepika Padukone

For more information please visit our Trasylol heart surgery stroke lawsuit center To learn more about Drug injury lawsuit please visit our website.

Please Rate this Article

Not yet Rated

Click the XML Icon Above to Receive Real Estate Articles Via RSS!

Additional Articles From - Home | Finance | Real Estate

Link building Service
Directory Submission Service
Seo Services Company
Article Syndication

	Print This Article
	Post Comment
	Add To Favorites
	Email to Friends
	Ezine Ready

Submit Articles
Member Login
Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds

Yoga's World
All Information On Yoga

Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds

New Stuff
About Us
Site Blog
Forum
Link to Us
Contact Us
Privacy Policy
Terms of Service

Ezine Article
Article Directory

EzinesArticle.Com » Copyright © 2006 ~ All Rights Reserved.
Terms of Service | Submission Guidelines | Contact Us | Link to Us